Mark Mallon - Mar 1, 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Executive Officer, Director
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 06:59 PM
Previous filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +142K +63.15% $0.00 368K Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +348K $0.00 348K Mar 1, 2022 Common Stock 348K $21.41 Direct F3
holding NEO Stock Option (Right to Buy) 151K Mar 1, 2022 Common Stock 151K $49.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Limited Power Of Attorney